Professor Langham is the Chief Medical Adviser of the Therapeutic Goods Administration in Australia.  She is a nephrologist and clinician researcher, focusing on drug development of novel anti-inflammatory and anti-fibrotic agents.  Professor Langham is also a director of the Australian Medical Council and chairs the Human Research and Ethics Committee at the Royal Children’s Hospital in Melbourne.